ChromaCode, Inc.

About

ChromaCode, Inc. is a molecular diagnostics and genomics company based in Carlsbad, California. The company specializes in HDPCR™ (High-Definition PCR) multiplexing technology, which enhances clinical molecular analysis through advanced digital signal processing and patented algorithms. Founded by experts from Illumina, Google[x], Luminex, and Caltech, ChromaCode develops software and reagent technologies that improve performance on existing molecular diagnostics platforms at a low cost. The flagship HDPCR™ platform is designed to work with standard laboratory dPCR, qPCR, or PCR systems without requiring new hardware or software installations. It offers over four times the multiplexing capability compared to conventional dPCR, enabling comprehensive coverage of clinically relevant biomarkers. ChromaCode provides reagent kits and cloud-based software that allow labs to conduct high-content tests efficiently, significantly reducing costs. The company targets large diagnostic labs, smaller academic labs, and global clinical diagnostics partners, focusing on scalable workflows and regulatory compliance to enhance molecular profiling capabilities.